FDA OCCUPATIONAL SAFETY, INDUSTRIAL HYGIENE, INFORMATION SYSTEMS, AND TRAINING (OSIST) IDIQ

Amendment No. 0001 – Industry Questions Regarding Draft Solicitation Documents

The purpose of this amendment is to encourage industry review of the draft solicitation package and associated documents and to invite the submission of questions for Government consideration prior to release of the final solicitation.

The Government encourages interested parties to review the draft solicitation, Performance Work Statements (PWSs), attachments, exhibits, pricing workbook, and all associated acquisition documents provided with this pre-solicitation notice. Offerors are encouraged to identify and submit questions, ambiguities, inconsistencies, or areas requiring clarification utilizing the attached R5_OSIST RFP Q&A Template.

The Government anticipates issuing the official solicitation with an abbreviated proposal response period following release. Accordingly, interested parties are strongly encouraged to conduct a thorough review of all draft solicitation materials and submit questions during this pre-solicitation phase. Early submission of questions will assist prospective offerors in preparing responsive proposals and facilitate a more efficient solicitation process.

Questions shall be submitted electronically using the Government-provided Q&A Template no later than Tuesday, June 16, 2026. The Government reserves the right to consolidate, paraphrase, or otherwise group similar questions when preparing responses. Responses to questions may be incorporated into the final solicitation, issued through solicitation amendments, or otherwise addressed at the Government's discretion.

Submission of questions during this pre-solicitation period is voluntary and is intended solely to assist the Government in refining solicitation requirements prior to issuance of the formal solicitation.

All other terms and conditions of the pre-solicitation synopsis remain unchanged.

Original

Description

The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), intends to issue a competitive Full and Open solicitation for the award of a single-award Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract for Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) support services.

The contemplated acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Products and Commercial Services; FAR Part 15, Contracting by Negotiation; and FAR Part 16.5, Indefinite-Delivery Contracts. The Government intends to award one (1) IDIQ contract resulting from Solicitation No. 75F40126R00020.

The resultant IDIQ contract is anticipated to support FDA enterprise-wide occupational safety, industrial hygiene, laboratory quality, biosafety, information systems, and training requirements through issuance of individual task orders. Task orders may be issued on a Firm-Fixed-Price (FFP), Time-and-Materials (T&M), Labor-Hour (LH), or hybrid basis.

The anticipated ordering period is five (5) years from date of award. The anticipated maximum contract ceiling is $14,500,000. The guaranteed minimum will be satisfied through issuance of the initial task order at time of award.

Services to be performed under the resultant IDIQ contract include, but are not limited to:

• Occupational safety and laboratory quality support services;
• Primary barrier equipment maintenance, repair, and certification;
• Industrial hygiene assessments and program support;
• Information and data systems support;
• Training development and management;
• Policy, compliance, and programmatic support services;
• BSL-3 laboratory re-verification and certification support;
• HVAC airflow and pressure differential testing;
• Vaporized hydrogen peroxide (VHP) decontamination services; and
• Biosafety compliance assessments aligned with CDC, NIH, USDA/APHIS, OSHA, ANSI, ISO, and related federal standards.

Primary performance will occur at FDA Headquarters located at the White Oak Federal Research Center, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, with additional performance possible at FDA facilities nationwide.

The Government is attaching a draft version of Solicitation No. 75F40126R00020 for industry review and planning purposes. The attached draft Request for Proposal (RFP) is provided to assist prospective offerors in understanding the anticipated scope and structure of the requirement and does not constitute the final solicitation. The draft solicitation is subject to change prior to formal issuance of the official solicitation on SAM.gov.

This synopsis and attached draft solicitation are issued for informational and planning purposes only. The Government is not requesting proposals, capability statements, comments, questions, or responses at this time. No contract award will be made as a result of this notice. Any future solicitation will be separately posted to SAM.gov.

The Government anticipates issuance of the formal solicitation on or about June 2026 via SAM.gov.

Important Notice to Interested Offerors

Offerors must be registered in the System for Award Management (SAM) at https://sam.gov at the time of proposal submission, prior to award, and throughout contract performance.

This notice is issued solely for informational and planning purposes and does not constitute a solicitation. This synopsis shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. The Government will not reimburse respondents for any costs incurred in preparation of responses to this notice.